En | De
Sie sind hier: ORL » Hals 29. März 2020
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 320  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 6388  
Current management of stage IV nasopharyngeal carcinoma without distant metastasis.
Cancer Treat Rev
Ng WT, Corry J, Langendijk JA, Lee AWM, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Smee R, Strojan P, Suárez C, Vermorken JB, Ferlito A.
PMID: 32113080 [PubMed - indexed for MEDLINE]

Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.
Anticancer Res
Psoma E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, Rontogianni D, Bobos M, Visvikis A, Kosmidis PA, Fountzilas G, Constantinidis J, Kalogera-Fountzila A.
PMID: 32014908 [PubMed - indexed for MEDLINE]

The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
Dwijayanti F, Prabawa A, Besral, Herawati C.
PMID: 31995803 [PubMed - indexed for MEDLINE]

Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: A population-based study.
Medicine (Baltimore)
Wu J, Zhou Q, Pan Z, Wang Y, Hu L, Chen G, Wang S, Lyu J.
PMID: 31977914 [PubMed - indexed for MEDLINE]

Isolated unilateral sixth nerve palsy in a patient with nasopharyngeal carcinoma.
Rom J Ophthalmol
Aghdam KA, Zand A, Sanjari MS.
PMID: 31915737 [PubMed - indexed for MEDLINE]

The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.
Medicine (Baltimore)
Liu J, Wei C, Tang H, Liu Y, Liu W, Lin C.
PMID: 31914029 [PubMed - indexed for MEDLINE]

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: Single-center experience from an endemic area.
Medicine (Baltimore)
Fangzheng W, Chuner J, Haiyan Q, Quanquan S, Zhimin Y, Tongxin L, Jiping L, Peng W, Kaiyuan S, Zhenfu F, Yangming J.
PMID: 31861031 [PubMed - indexed for MEDLINE]

CUL4A expression is associated with tumor stage and prognosis in nasopharyngeal carcinoma.
Medicine (Baltimore)
Jin X, Ma YC, Zhu WY, Fan L.
PMID: 31860954 [PubMed - indexed for MEDLINE]

Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Cancer Sci
Zheng XH, Wang RZ, Li XZ, Zhou T, Zhang JB, Zhang PF, Lu LX, Jia WH.
PMID: 31834989 [PubMed - indexed for MEDLINE]

Impact of RTN4 gene polymorphism and its plasma level on susceptibility to nasopharyngeal carcinoma: A case-control study.
Medicine (Baltimore)
Yang F, Yang S, Liu J, Pang X, Shi F, Qin H, Wang J, Tang R.
PMID: 31764777 [PubMed - indexed for MEDLINE]

MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X, Zhu D, Zhang H, Zhang S, Zhou X, He X, Zhu J, Zhu W.
PMID: 31743768 [PubMed - indexed for MEDLINE]

Association Between LMP-1, LMP-2, and miR-155 Expression as Potential Biomarker in Nasopharyngeal Carcinoma Patients: A Case/Control Study in Vietnam.
Genet Test Mol Biomarkers
Lao TD, Le TAH.
PMID: 31693455 [PubMed - indexed for MEDLINE]

Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
J Cancer Res Clin Oncol
Liao S, Xie Y, Feng Y, Zhou Y, Pan Y, Fan J, Mi J, Qin X, Yao D, Jiang W.
PMID: 31677113 [PubMed - indexed for MEDLINE]

Low-Grade Nasopharyngeal Papillary Adenocarcinoma.
J Coll Physicians Surg Pak
Wang L, Min Q, Jiang J, Shao Y, Cao Y, Yan D.
PMID: 31659975 [PubMed - indexed for MEDLINE]

Efficacy of endoscopy in assessing the local disease response in nasopharyngeal carcinoma patients after treated with intensity-modulated radiotherapy.
Asia Pac J Clin Oncol
Ng JTY, Yu KS, Poon DMC.
PMID: 31642178 [PubMed - indexed for MEDLINE]

Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.
Radiat Oncol
Zong J, Xu H, Chen B, Guo Q, Xu Y, Chen C, Weng Y, Zheng W, Pan J, Lin S.
PMID: 31640719 [PubMed - indexed for MEDLINE]

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).
Dong D, Zhang F, Zhong LZ, Fang MJ, Huang CL, Yao JJ, Sun Y, Tian J, Ma J, Tang LL.
PMID: 31640711 [PubMed - indexed for MEDLINE]

A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma.
Medicine (Baltimore)
Wang BC, Shi LL, Fu C, Zhou HX, Zhang ZJ, Ding Q, Peng G.
PMID: 31626102 [PubMed - indexed for MEDLINE]

Current Perspectives on Nasopharyngeal Carcinoma.
Adv Exp Med Biol
Lee HM, Okuda KS, González FE, Patel V.
PMID: 31576537 [PubMed - indexed for MEDLINE]

Immune infiltration in nasopharyngeal carcinoma based on gene expression.
Medicine (Baltimore)
Luo MS, Huang GJ, Liu BX.
PMID: 31574860 [PubMed - indexed for MEDLINE]

   Artikel 1 - 20 / 6388    Seite 1 von 320  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1